BIOGEND THERAPEUTICS CO LTD has a total of 15 patent applications. It decreased the IP activity by 92.0%. Its first patent ever was published in 2016. It filed its patents most often in Taiwan, Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are CERAPEDICS INC, DESMOS INC and JELLAGEN PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | United States | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Sun Da-Wei | 14 |
#2 | Chen Chien-Pei | 8 |
#3 | Hsu Pei-Wen | 7 |
#4 | Sun Da Wei | 1 |
Publication | Filing date | Title |
---|---|---|
TW201915028A | Recombinant polypeptides, compositions, and methods thereof | |
WO2018122794A1 | Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof | |
CN108264568A | Recombinant polypeptide, nucleic acid molecules and combinations thereof and manufacture use its method | |
TWI621435B | Pharmaceutical composition of Minocycline and manufacturing method thereof |